BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 3497172)

  • 1. Occult bacteremia with nontypeable Haemophilus influenzae.
    Rubin LG; Staiman K; Kamani N
    J Clin Microbiol; 1987 Jul; 25(7):1314-5. PubMed ID: 3497172
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular characteristics of Haemophilus influenzae causing invasive disease during the period of vaccination in Switzerland: analysis of strains isolated between 1986 and 1993.
    Muhlemann K; Balz M; Aebi S; Schopfer K
    J Clin Microbiol; 1996 Mar; 34(3):560-3. PubMed ID: 8904414
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of capsular genes in Haemophilus influenzae isolates from H. influenzae type b vaccine recipients.
    Falla TJ; Crook DW; Anderson EC; Ward JI; Santosham M; Eskola J; Moxon ER
    J Infect Dis; 1995 Apr; 171(4):1075-6. PubMed ID: 7706799
    [No Abstract]   [Full Text] [Related]  

  • 4. Immunogenicity of Haemophilus influenzae type b polysaccharide-outer membrane protein conjugate vaccine in patients who acquired Haemophilus disease despite previous vaccination with type b polysaccharide vaccine.
    Granoff DM; Chacko A; Lottenbach KR; Sheetz KE
    J Pediatr; 1989 Jun; 114(6):925-33. PubMed ID: 2786062
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Invasive serotype a Haemophilus influenzae infections with a virulence genotype resembling Haemophilus influenzae type b: emerging pathogen in the vaccine era?
    Adderson EE; Byington CL; Spencer L; Kimball A; Hindiyeh M; Carroll K; Mottice S; Korgenski EK; Christenson JC; Pavia AT
    Pediatrics; 2001 Jul; 108(1):E18. PubMed ID: 11433097
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nontypeable Haemophilus influenzae as a pathogen in children.
    Murphy TF; Faden H; Bakaletz LO; Kyd JM; Forsgren A; Campos J; Virji M; Pelton SI
    Pediatr Infect Dis J; 2009 Jan; 28(1):43-8. PubMed ID: 19057458
    [TBL] [Abstract][Full Text] [Related]  

  • 7. No evidence for Haemophilus influenzae serotype replacement in Europe after introduction of the Hib conjugate vaccine.
    Ladhani S; Ramsay ME; Chandra M; Slack MP;
    Lancet Infect Dis; 2008 May; 8(5):275-6. PubMed ID: 18471770
    [No Abstract]   [Full Text] [Related]  

  • 8. Vaccination against Haemophilus influenzae type B.
    Lancet; 1986 May; 1(8489):1074-5. PubMed ID: 2871342
    [No Abstract]   [Full Text] [Related]  

  • 9. Changes in the distribution of Haemophilus influenzae type b clones associated with widespread infant vaccination in Finland.
    van Alphen L; Takala AK; Geelen-van den Broek L; Dankert J; Eskola J
    J Infect Dis; 1992 Dec; 166(6):1340-5. PubMed ID: 1431251
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of encapsulation and host age in the clearance of Haemophilus influenzae bacteremia.
    Weller PF; Smith AL; Anderson P; Smith DH
    J Infect Dis; 1977 Jan; 135(1):34-41. PubMed ID: 299866
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Statement on Haemophilus influenzae type b polysaccharide vaccine.
    CMAJ; 1986 Jun; 134(12):1375-6. PubMed ID: 3486707
    [No Abstract]   [Full Text] [Related]  

  • 12. Polysaccharide vaccine for prevention of Haemophilus influenzae type b disease.
    Leung AK; Jadavji T
    J R Soc Health; 1988 Oct; 108(5):180-1. PubMed ID: 3148720
    [No Abstract]   [Full Text] [Related]  

  • 13. Infections caused by Haemophilus influenzae type b. The beginning of the end?
    Shapiro EP
    JAMA; 1993 Jan; 269(2):264-6. PubMed ID: 8417247
    [No Abstract]   [Full Text] [Related]  

  • 14. Haemophilus influenzae type b polysaccharide vaccine.
    Cates KL
    Pediatr Ann; 1986 Jun; 15(6):461-3, 467-8. PubMed ID: 3523406
    [No Abstract]   [Full Text] [Related]  

  • 15. A virulent nonencapsulated Haemophilus influenzae.
    Nizet V; Colina KF; Almquist JR; Rubens CE; Smith AL
    J Infect Dis; 1996 Jan; 173(1):180-6. PubMed ID: 8537657
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Haemophilus influenzae infections following licensure of the Hib vaccine.
    Alexander WJ; Shaw JF; Holmes JR
    N Engl J Med; 1987 Jul; 317(3):167-8. PubMed ID: 3496536
    [No Abstract]   [Full Text] [Related]  

  • 17. Host and bacterial factors associated with Haemophilus influenzae type b disease in Minnesota children vaccinated with type b polysaccharide vaccine.
    Granoff DM; Sheetz K; Pandey JP; Nahm MH; Rambeck JH; Jacobs JL; Musser J; Selander RK; Kabeer M; Murphy TV
    J Infect Dis; 1989 May; 159(5):908-16. PubMed ID: 2785147
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and efficacy of Haemophilus influenzae type b polysaccharide vaccine.
    Granoff DM; Osterholm MT
    Pediatrics; 1987 Oct; 80(4):590-2. PubMed ID: 3498928
    [No Abstract]   [Full Text] [Related]  

  • 19. The introduction of Haemophilus influenzae B (Hib) vaccine.
    Murphy JF
    Ir Med J; 1992 Dec; 85(4):123. PubMed ID: 1473940
    [No Abstract]   [Full Text] [Related]  

  • 20. Differential complement resistance mediates virulence of Haemophilus influenzae type b.
    Sutton A; Schneerson R; Kendall-Morris S; Robbins JB
    Infect Immun; 1982 Jan; 35(1):95-104. PubMed ID: 6976328
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.